Death Causes Several Brazilian States to Halt AstraZeneca COVID-19 Vaccinations of Pregnant Women; Not Yet Approved for Use in U.S.

The AstraZeneca COVID-19 vaccine has not yet been approved for use in the United States, where it is currently in large-scale (Phase 3) clinical trials and is expected to be potentially approved in the coming weeks, according to White House press secretary Jen Psaki. File photo: Marc Bruxelle, Shutterstock.com, licensed.
The AstraZeneca COVID-19 vaccine has not yet been approved for use in the United States, where it is currently in large-scale (Phase 3) clinical trials and is expected to be potentially approved in the coming weeks, according to White House press secretary Jen Psaki. File photo: Marc Bruxelle, Shutterstock.com, licensed.

BRAZIL – Following the recommendation of Anvisa, national regulator in Brazil, the AstraZeneca COVID-19 vaccine program was suspended on Tuesday for pregnant women in several states in the South American country after a death occurred in Rio de Janeiro, according to reports. Rio has reportedly halted vaccinations of all women, while Sao Paulo has suspended them for women with pre-existing medical conditions who are pregnant.

Folha de S. Paulo, a Brazilian news outlet, reported that a pregnant woman in Rio de Janeiro who had received the AstraZeneca COVID-19 shot later died; the incident is being investigated by the country’s health ministry to see if the vaccine could have played a part in the woman’s demise.

With the suspension of the AstraZeneca vaccine and a shortage of vaccines from other manufacturers in Brazil at the moment, pregnant women reportedly have almost no options when it comes to getting inoculated against the COVID-19 pandemic until after the health ministry concludes its inquiry, providing that the AstraZeneca drug is indeed deemed safe.



Big Tech is censoring our publication severely reducing our traffic and revenue. (Wanna learn how they do it? NewsGuard) You can support our mission of truthful reporting by making a contribution. We refuse to let Silicon Valley crush us into becoming just another regurgitated, propaganda driven, echo-chamber of traditional news media and we need your support. You can also help by liking or sharing us on social media or by signing up for our featured story emails.
 

While it is being used in several countries at the moment, the AstraZeneca COVID-19 vaccine has not yet been approved for use in the United States, where it is currently in large-scale (Phase 3) clinical trials and is expected to be potentially approved in the “coming weeks,” according to White House press secretary Jen Psaki.

Reuters previously reported that AstraZeneca had excluded pregnant and breastfeeding women from their clinical trials, but that animal-based tests didn’t show any issues with “pregnancy or fetal development.”

Comment via Facebook

Corrections: If you are aware of an inaccuracy or would like to report a correction, we would like to know about it. Please consider sending an email to corrections@publishedreporter.com and cite any sources if available. Thank you. (Policy)